1985
DOI: 10.1016/0196-9781(85)90168-8
|View full text |Cite
|
Sign up to set email alerts
|

Administered peptides inhibit the degradation of endogenous peptides. The dilemma of distinguishing direct from indirect effects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
13
0
1

Year Published

1992
1992
2006
2006

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 34 publications
(14 citation statements)
references
References 228 publications
0
13
0
1
Order By: Relevance
“…The negative correlations between BENDI levels in CSF and those in the NTS area may indicate that BEND has been released in the NTS area. Released BEND is usually broken down by peptidases [45], and the increase in CSF peptides may be due to immature peptidases or by their inhibition by other peptides [24]. If insufficient peptide breakdown is combined with increased activity in the BEND-ACTH axis, a steady increase in BEND may reach levels that cause respiratory depression, bradycardia and hypotension [1,17,38].…”
Section: Discussionmentioning
confidence: 99%
“…The negative correlations between BENDI levels in CSF and those in the NTS area may indicate that BEND has been released in the NTS area. Released BEND is usually broken down by peptidases [45], and the increase in CSF peptides may be due to immature peptidases or by their inhibition by other peptides [24]. If insufficient peptide breakdown is combined with increased activity in the BEND-ACTH axis, a steady increase in BEND may reach levels that cause respiratory depression, bradycardia and hypotension [1,17,38].…”
Section: Discussionmentioning
confidence: 99%
“…In addition to metabolites, the presence of any endogenous substance can also have a profound effect on analytical results if they exist in high quantities. This is often the case for peptides; a good review of this consideration for peptides is provided by LaBella et al (1985). The presence of antibodies may interfere with the assay of the molecule of interest and, similarly, the molecule of interest may interfere with the antibody assay.…”
Section: Assay Interferencementioning
confidence: 98%
“…Endogenous effects must be controlled for in elucidating mechanisms and in distinguishing the effects of exogenously administered drug. A good review of this dilemma with respect to peptides is available (laBella et al 1985). Control of endogenous interference is equally true for delineation of accurate pharmacokinetics of exogenously administered peptides and proteins.…”
Section: Endogenous Interferencementioning
confidence: 99%
“…As we will'see later, endogenous binding proteins play an important role in the modulation of the biological activity and pharmacokinetics of certain macromolecular substances. By the very nature of their affinity and specificity for these mac~omolecules, the potential impact of these binding proteins upon immunoassay methods designed to quantify these macromolecules may be significant (19,20) due to them competing with the immunoassay antibody for the antigen (the molecule being quantified). In vivo antibody formation in response to administration of a foreign therapeutic protein may impact immunoassay methodology in the same way as endogenous binding proteins.…”
Section: Bioanalysismentioning
confidence: 99%